News

FDA vaccine official restricted COVID vaccine approvals against the advice of agency staff
The government’s top vaccine official working under Health Secretary Robert F. Kennedy Jr. recently restricted the approval ...
CNN1mon
After delay, FDA approves Novavax’s Covid-19 vaccine, but only for ...
After a six-week delay, the US Food and Drug Administration has approved Novavax’s Covid-19 vaccine, according to a letter from the agency, but only for people 65 and older and those 12 and up ...
WebMD1mon
FDA Approves Novavax COVID Vaccine With Restricted Use - WebMD
The FDA has approved the Novavax COVID-19 vaccine, called Nuvaxovid, mainly for adults 65 or older, but people ages 12 to 64 with medical conditions that increase their risk of serious illness ...
UPI1mon
FDA approves Novavax's COVID-19 vaccine with limitations - UPI
May 18 (UPI) --The U.S. Food and Drug Administration approved Novavax's COVID-19 vaccine with age restrictions after a six-week delay. The agency approved the vaccine only for people 65 and older ...
Healio1mon
FDA approves Novavax’s COVID-19 vaccine — with restrictions - Healio
The FDA has approved Novavax’s protein-based COVID-19 vaccine, giving some Americans another option besides messenger RNA vaccines to prevent SARS-CoV-2 infection.
PBS1mon
FDA approves Novavax COVID-19 vaccine, but with unusual restrictions on its use
In its Friday approval letter, the FDA didn’t explain the restrictions although they reflect skepticism about vaccines from Health Secretary Robert F. Kennedy Jr. and other Trump officials.
Reuters1mon
FDA approves Novavax COVID vaccine with new conditions
May 17 (Reuters) - The U.S. Food and Drug Administration approved Novavax's , opens new tab COVID-19 vaccine, but limited its use to older adults and people over the age of 12 with conditions that ...
New York Post1mon
FDA approves Moderna’s next-generation COVID vaccine for adults 65 or ...
The FDA approved Novavax’s COVID vaccine Nuvaxovid this month, limiting its use to older adults and people over the age of 12 with conditions that put them at risk due to the illness.
Hosted on MSN1mon
After delay, FDA approves Novavax’s Covid-19 vaccine, but only for older people and those at high risk
After a six-week delay, the US Food and Drug Administration has approved Novavax’s Covid-19 vaccine, according to a letter from the agency, but only for people 65 and older and those 12 and up ...
CNN1mon
After delay, FDA approves Novavax’s Covid-19 vaccine, but only for older people and those at high risk | CNN - CNN International
After a six-week delay, the US Food and Drug Administration has approved Novavax’s Covid-19 vaccine, according to a letter from the agency, but only for people 65 and older and those 12 and up ...
Monthly Prescribing Reference1mon
FDA Approves Novavax's COVID-19 Vaccine Nuvaxovid - MPR
The Food and Drug Administration (FDA) has approved Nuvaxovid ™ (COVID-19 Vaccine, Adjuvanted) for active immunization to prevent COVID-19 caused by SARS-Cov-2 in adults 65 years and older and ...
clinicaladvisor.com1mon
FDA Approves Novavax’s COVID-19 Vaccine Nuvaxovid
The Food and Drug Administration (FDA) has approved Nuvaxovid ™ (COVID-19 Vaccine, Adjuvanted) for active immunization to prevent COVID-19 caused by SARS-Cov-2 in adults 65 years and older and ...